Jagsonpal Pharmaceuticals Reaches All-Time High, Outperforms Sector and Market Averages
Jagsonpal Pharmaceuticals Ltd. has reached an all-time high price of Rs.620 on November 7th, 2024, with a consecutive gain of 14.73% in the last three days. The stock is currently trading higher than its moving averages and has outperformed the sector by 2.31%. With a strong performance in the past year, the company shows potential in the pharmaceutical industry.
Jagsonpal Pharmaceuticals Ltd., a smallcap company in the pharmaceuticals and drugs industry, has reached an all-time high price of Rs.620 on November 7th, 2024. This news comes as the stock has been gaining for the last three days, with a consecutive gain of 14.73% during this period. The stock opened with a gap up of 2.31% today and has since traded at this price, touching an intraday high of Rs.620.
According to MarketsMOJO, a leading stock analysis and recommendation platform, the stock call for Jagsonpal Pharmaceuticals is 'Hold'. The company's performance today has also outperformed the sector by 2.31%. Additionally, Jagsonpal Pharma is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.
In the past year, Jagsonpal Pharmaceuticals has shown a strong performance with a 52.61% increase in its stock price, compared to the Sensex's 23.59% performance. This highlights the company's growth and potential in the pharmaceutical industry.
As a smallcap company, Jagsonpal Pharmaceuticals has shown promising growth and potential in the market. With its recent all-time high price and consistent gains, the company is definitely one to watch in the pharmaceutical industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
